MEDICO REMEDIES
Quarterly Results Analysis [Jun2024]
MEDICO REMEDIES Quarterly Results
Standalone | Jun2024 Audited |
Mar2024 Audited |
Dec2023 UnAudited |
Sep2023 Audited |
Jun2023 UnAudited |
Mar2023 UnAudited |
Dec2022 UnAudited |
Sep2022 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹31 Cr | ₹41 Cr | ₹30 Cr | ₹42 Cr | ₹31 Cr | ₹28 Cr | ₹39 Cr | ₹40 Cr |
Expenses | ₹28 Cr | ₹37 Cr | ₹27 Cr | ₹39 Cr | ₹29 Cr | ₹25 Cr | ₹35 Cr | ₹37 Cr |
Operating Income | ₹3 Cr | ₹5 Cr | ₹3 Cr | ₹3 Cr | ₹2 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr |
Other Income | ₹0 Cr | ₹1 Cr | ₹0 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹2 Cr |
Interest | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Depreciation | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
Profit Before Tax | ₹2 Cr | ₹4 Cr | ₹2 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹3 Cr | ₹4 Cr |
Profit After Tax | ₹2 Cr | ₹3 Cr | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹2 Cr | ₹2 Cr | ₹3 Cr |
EPS | ₹0.19 | ₹0.37 | ₹0.17 | ₹0.29 | ₹0.16 | ₹0.21 | ₹0.05 | ₹0.07 |
Industry Peers & Returns | 1W | 1M | 1Y |
MEDICO REMEDIES | 1% | 21.5% | -22.6% |
SUN PHARMACEUTICAL INDUSTRIES | 0.1% | -4% | 52.9% |
CIPLA | 0.5% | -1.7% | 29.4% |
DR REDDYS LABORATORIES | 1.1% | -2.6% | 19.2% |
ZYDUS LIFESCIENCES | -3.6% | -8.4% | 62.9% |
DIVIS LABORATORIES | 0.7% | -0% | 70.9% |
MANKIND PHARMA | -2.8% | -0.7% | 52% |
TORRENT PHARMACEUTICALS | -0.1% | -7.2% | 58.1% |
LUPIN | -3.9% | -2.4% | 77.5% |
MEDICO REMEDIES Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -25.47 % |
Y-o-Y | -2.14 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Jun2024 | ₹31 Cr | -25.47 | |
Mar2024 | ₹41 Cr | 38.80 | |
Dec2023 | ₹30 Cr | -29.71 | |
Sep2023 | ₹42 Cr | 34.59 | |
Jun2023 | ₹31 Cr | 12.42 | |
Mar2023 | ₹28 Cr | -27.94 | |
Dec2022 | ₹39 Cr | -3.99 | |
Sep2022 | ₹40 Cr | - |
MEDICO REMEDIES Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | -39.52 % |
Y-o-Y | 14.41 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Jun2024 | ₹3 Cr | -39.52 | |
Mar2024 | ₹5 Cr | 70.06 | |
Dec2023 | ₹3 Cr | -11.21 | |
Sep2023 | ₹3 Cr | 25.29 | |
Jun2023 | ₹2 Cr | -22.38 | |
Mar2023 | ₹3 Cr | -6.61 | |
Dec2022 | ₹3 Cr | 7.66 | |
Sep2022 | ₹3 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -18.86 % |
Y-o-Y | 16.92 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Jun2024 | 9.12% | -18.86 | |
Mar2024 | 11.24% | 22.44 | |
Dec2023 | 9.18% | 26.45 | |
Sep2023 | 7.26% | -6.92 | |
Jun2023 | 7.8% | -30.97 | |
Mar2023 | 11.3% | 29.59 | |
Dec2022 | 8.72% | 12.08 | |
Sep2022 | 7.78% | - |
MEDICO REMEDIES Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -49.05 % |
Y-o-Y | 19.53 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Jun2024 | ₹2 Cr | -49.05 | |
Mar2024 | ₹3 Cr | 114.46 | |
Dec2023 | ₹1 Cr | -40.44 | |
Sep2023 | ₹2 Cr | 83.65 | |
Jun2023 | ₹1 Cr | -25.24 | |
Mar2023 | ₹2 Cr | -21.43 | |
Dec2022 | ₹2 Cr | -21.61 | |
Sep2022 | ₹3 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -31.60 % |
Y-o-Y | 22.14 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Jun2024 | 5.13 % | -31.60 | |
Mar2024 | 7.5 % | 54.64 | |
Dec2023 | 4.85 % | -15.36 | |
Sep2023 | 5.73 % | 36.43 | |
Jun2023 | 4.2 % | -33.44 | |
Mar2023 | 6.31 % | 8.98 | |
Dec2022 | 5.79 % | -18.34 | |
Sep2022 | 7.09 % | - |
MEDICO REMEDIES Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -48.65 % |
Y-o-Y | 18.75 % |
Quarters | EPS | % Change | |
---|---|---|---|
Jun2024 | ₹0.19 | -48.65 | |
Mar2024 | ₹0.37 | 117.65 | |
Dec2023 | ₹0.17 | -41.38 | |
Sep2023 | ₹0.29 | 81.25 | |
Jun2023 | ₹0.16 | -23.81 | |
Mar2023 | ₹0.21 | 320.00 | |
Dec2022 | ₹0.05 | -28.57 | |
Sep2022 | ₹0.07 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD